Juan Francisco Delgado Jiménez

Full Professor

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Juan Francisco Delgado Jiménez is a Full Professor at Hospital Universitario 12 de Octubre Centro de Investigación Biomédica in Spain. His research areas include pulmonary arterial hypertension, heart failure management, and the effects of mRNA COVID-19 vaccines on cardiovascular health. He has recently authored several articles exploring advanced imaging techniques for pulmonary vascular assessment and the management of heart failure post-discharge. His work contributes significantly to the understanding of cardiovascular diseases and their implications in chronic illnesses.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (2)

Carlos Escobar

SPAIN

View details

Domingo A. Pascual Figal

Full Professor (Catedrático)

Universidad de Murcia

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Juan Francisco Delgado Jiménez

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Comparison of Tricuspid Annular Plane Systolic Excursion to Pulmonary Artery Systolic Pressure Ratio Measured by Transthoracic Echocardiography and Right Heart Catheterization in Pulmonary Arterial Hypertension: Prognostic Implications

Four-Dimensional Magnetic Resonance Pulmonary Flow Imaging for Assessing Pulmonary Vasculopathy in Patients with Postcapillary Pulmonary Hypertension

Colchicine in acutely decompensated heart failure: the COLICA trial

The Role of Cardiac Magnetic Resonance in mRNA COVID-19 Vaccine-Related Myopericarditis: An Evolutive Case Series

Circadian pattern of heart rate in patients with heart failure. Response

Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease

N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction - a randomized trial: The NICE study

Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction

Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction

Patrones de presión arterial de 24 horas en pacientes con insuficiencia cardiaca estable. Prevalencia y factores asociados

Patrones de presión arterial de 24 horas en pacientes con insuficiencia cardiaca estable. Prevalencia y factores asociados

β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure ( <scp>SPHERE‐HF</scp> ): a double blind, placebo‐controlled, randomized clinical trial

beta 3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial

Best practices during COVID-19 pandemic in solid organ transplant programs in Spain

Best practices during COVID-19 pandemic in solid organ transplant programs in Spain

De Novo Donor-Specific Antibodies after Heart Transplantation: A Comprehensive Guide for Clinicians

Interaction between VA-ECMO and the right ventricle

Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain

Collaborators (2)

Carlos Escobar

Domingo A. Pascual Figal

Make your next move.